BioLineRx Ltd. EV 2011-2026 | BLRX

EV Jährlich BioLineRx Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15 M	46.4 M	15 M	1.35 B	50.9 M	36.9 M	59.3 M	101 M	60.4 M	51.1 M	62.8 M	73.9 M	86.4 M	53.9 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
1.35 B	15 M	148 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Aquestive Therapeutics AQST	540 M	$ 4.14	0.36 %	$ 443 M	USA
Arcturus Therapeutics Holdings ARCT	43.4 M	$ 8.41	4.73 %	$ 230 M	Israel
Ardelyx ARDX	1.89 B	$ 6.06	1.94 %	$ 1.46 B	USA
argenx SE ARGX	-2.13 B	$ 752.35	0.79 %	$ 25 B	Niderland
Arcutis Biotherapeutics ARQT	3.64 B	$ 23.83	0.85 %	$ 3.03 B	USA
Aytu BioScience AYTU	-15.2 M	$ 2.65	-1.12 %	$ 16.6 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
BioCardia BCDA	8.09 M	$ 1.2	-0.04 %	$ 8 M	USA
BioCryst Pharmaceuticals BCRX	2.58 B	$ 9.6	6.37 %	$ 1.98 B	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	10.2 B	$ 9.48	-3.27 %	$ 613 M	USA
BioVie BIVI	-12.6 M	$ 1.45	2.09 %	$ 2.14 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
BioMarin Pharmaceutical BMRN	11.9 B	$ 56.49	1.78 %	$ 10.8 B	USA
BioNTech SE BNTX	-4.91 B	$ 92.3	1.23 %	$ 27.2 B	Germany
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	197 M	$ 3.04	1.54 %	$ 259 M	USA
BioXcel Therapeutics BTAI	127 M	$ 1.16	-2.12 %	$ 14.2 M	USA
Burford Capital Limited BUR	3.22 B	$ 4.54	9.54 %	$ 683 M	Britain
Cabaletta Bio CABA	253 M	$ 3.2	7.94 %	$ 322 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.21	4.56 %	$ 6.98 B	Israel
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Catalyst Biosciences CBIO	986 M	$ 19.97	2.94 %	$ 1.78 B	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Codexis CDXS	157 M	$ 1.97	7.97 %	$ 172 M	USA
Cerus Corporation CERS	632 M	$ 1.91	2.42 %	$ 364 M	USA
Cullinan Management CGEM	850 M	$ 15.4	6.72 %	$ 928 M	USA
Coherus BioSciences CHRS	335 M	$ 1.75	0.87 %	$ 205 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain